Gataca
GATACA is a Virginia-based bioinformatics software company focused on developing pathogen-specific solutions for virologists, leveraging deep machine learning and bioinformatics algorithms. Their flagship product, GAT/ML™, is a pioneering software pipeline for viral next-generation sequencing (NGS) *de novo* assembly, designed to discover emerging variants in real-time and provide predictive insights. Currently specialized for Hepatitis (HBV) and Human Immunodeficiency Virus (HIV) analytics, GAT/ML™ is alignment-free and reference-free, capable of reconstructing quasispecies and predicting functional traits. The company has received significant funding through Small Business Innovation Research (SBIR) awards from the NSF and NIH, and state awards from VIPC. GATACA aims to revolutionize virology research and healthcare by offering precise analysis of viral populations and diseases, with applications in drug development, clinical trials, and academic research.
Gataca
GATACA is a Virginia-based bioinformatics software company focused on developing pathogen-specific solutions for virologists, leveraging deep machine learning and bioinformatics algorithms. Their flagship product, GAT/ML™, is a pioneering software pipeline for viral next-generation sequencing (NGS) *de novo* assembly, designed to discover emerging variants in real-time and provide predictive insights. Currently specialized for Hepatitis (HBV) and Human Immunodeficiency Virus (HIV) analytics, GAT/ML™ is alignment-free and reference-free, capable of reconstructing quasispecies and predicting functional traits. The company has received significant funding through Small Business Innovation Research (SBIR) awards from the NSF and NIH, and state awards from VIPC. GATACA aims to revolutionize virology research and healthcare by offering precise analysis of viral populations and diseases, with applications in drug development, clinical trials, and academic research.